Evaluating the antidiabetic effects of Chinese herbal medicine: Xiao-Ke-An in 3T3-L1 cells and KKAy mice using both conventional and holistic omics approaches-Reference-Cited by-同舟云学术

Evaluating the antidiabetic effects of Chinese herbal medicine: Xiao-Ke-An in 3T3-L1 cells and KKAy mice using both conventional and holistic omics approaches

Published:2015-08-13 Issue:1 Volume:15 Page:
ISSN:1472-6882
Container-title:BMC Complementary and Alternative Medicine
language:en
Short-container-title:BMC Complement Altern Med

Author:

Yang Zhenzhong,Wang Linli,Zhang Feng,Li Zheng

Publisher

Springer Science and Business Media LLC

Subject

Complementary and alternative medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12906-015-0785-2.pdf

Reference25 articles.

1. Holman RR. Type 2 diabetes mellitus in 2012: Optimal management of T2DM remains elusive. Nat Rev Endocrinol. 2013;9(2):67–8.

2. Tahrani AA, Bailey CJ, Del Prato S, Barnett AH. Management of type 2 diabetes: new and future developments in treatment. Lancet. 2011;378(9786):182–97.

3. Gu J, Zhang H, Chen L, Xu S, Yuan G, Xu X. Drug–target network and polypharmacology studies of a Traditional Chinese Medicine for type II diabetes mellitus. Comput Biol Chem. 2011;35(5):293–7.

4. Berger SI, Iyengar R. Network analyses in systems pharmacology. Bioinformatics. 2009;25(19):2466–72.

5. Mopuri R, Ganjayi M, Banavathy KS, Parim BN, Meriga B. Evaluation of anti-obesity activities of ethanolic extract of Terminalia paniculata bark on high fat diet-induced obese rats. BMC Complement Altern Med. 2015;15(1):76.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic Studies of Chinese Herbal Medicine: Pleiotropic Role of DNA Methylation;Frontiers in Pharmacology;2021-12-07

2. Exploring the Hypoglycaemic Mechanism of Chinese Medicine Xiao‐Ke‐An Based on Target Dipeptidyl Peptidase 4 Using Molecular Docking and Dynamics Simulation;ChemistrySelect;2021-08-18

3. In Vitro Culture Techniques and Metabolite Engineering for Enhanced Antidiabetic Secondary Metabolite Production;Biotechnology of Anti-diabetic Medicinal Plants;2021

4. The potential DPP-4 inhibitors from Xiao-Ke-An improve the glucolipid metabolism via the activation of AKT/GSK-3β pathway;European Journal of Pharmacology;2020-09

5. Target recognition and network pharmacology for revealing anti-diabetes mechanisms of natural product;Journal of Computational Science;2020-09